Evado signs distribution deal
Monday, 14 April, 2008
Specialist life science training, quality assurance and regulatory compliance company SeerPharma has signed a re-seller agreement with Evado, a division of Australian company Invision IT Systems.
SeerPharma will distribute Evado's new web-based enterprise pre-clinical, clinical and mobile software modules in the SE Asian region. SeerPharma will also offer Evado as a software-as-a-service (SaaS) application to its medical device, biotechnology and life science clients.
Evado is a form-based technology that replaces the paper-based case report forms with easy to customise templates that are suitable for drug or device trials.
"Evado was created to provide a simple, easy-to-use, economical alternative to expensive clinical trial software," Evado's CEO Jennie Anderson said.
"Evado helps speed up clinical trials and assists researchers in the development of new medical therapies and medical devices by reducing costs and by improving data accuracy thereby achieving quicker regulatory approvals and time to market."
Heart muscle regeneration genes mapped
Researchers have uncovered insights into how stem cells develop and mature into heart muscle...
The cause of 2022's mpox outbreak revealed
Researchers have discovered that the strain of mpox behind the 2022 outbreak was a weakened form...
New gene therapy treats liver disorder in growing children
Researchers have developed a genome-editing approach that repairs a faulty gene directly at its...
